Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase Inhibitors (Cabozantinib [NSC #761968], Crizotinib [NSC #749005], Savolitinib [NSC #785348], and Sunitinib [NSC #736511]) in Metastatic Papillary Renal Carcinoma (PAPMET)
Disease/Condition   Kidney Diseases (incl Chronic Kidney Disease),Kidney Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Carcinoma,Urogenital Neoplasms
Description  

Click here for more information

Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Benjamin Gartrell, MD
Contact Name   Gina Aracena
Contact Email   gihernan@montefiore.org
Protocol Number   2017-7787
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Adult, Pediatric, Both   Adult